COLLAGE
LIVE

Serial Number

98824432

Owner

Collage Bio Inc.

Attorney

Christina M. Licursi

Filing Date

Oct 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

COLLAGE Trademark

Serial Number: 98824432

COLLAGE is a trademark filed by Collage Bio Inc. on October 28, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Collage Bio Inc.

3000 Sand Hill Road
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

October 28, 2024

Registration Date

Not Registered

Published for Opposition

December 2, 2025

Goods & Services

Pharmaceutical research and development; scientific research and development; medical research and development in the field of medical preparations; pharmaceutical research and analysis services using machine learning analytics for drug efficacy and safety; technical consultation services and product development for others in the fields of biotechnology and pharmaceuticals; pharmaceutical and scientific research and development relating to RNA targeting and assay development; platform as a service (PaaS) featuring computer software platforms for performing drug discovery and development and biotechnology research; pharmaceutical drug development services related to proteins, ribosomes, RNA, and DNA

Pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders; pharmaceutical preparations, namely, RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics; biopharmaceutical preparations and agents, namely, pharmaceutical preparations for the treatment of genetic and genomic diseases and disorders, neurological diseases and disorders, muscular diseases and disorders, neuromuscular diseases and disorders, cardiovascular diseases and disorders, metabolic diseases and disorders, cardiometabolic diseases and disorders, endocrine diseases and disorders, and kidney diseases and disorders, and RNA medicines, oligonucleotide therapeutics, and polynucleotide therapeutics

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 27, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 2, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 2, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 3, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 3, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 3, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 7, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 7, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 8, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 8, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 8, 2025 CNRT
ASSIGNED TO EXAMINER
Apr 29, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2025 NWOS
NEW APPLICATION ENTERED
Oct 28, 2024 NWAP